Polypeptides and polynucleotides related to the pa-i lectin of pseudomonas aeruginosa
CA 2109337 A1 · Owner: Garber, Nachman C. · Inventors: Garber, Nachman C.; Gilboa-Garber, Nechama; Avichezer, Dody
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An isolated, recombinant or synthetic polypeptide (corresponding with PA-I lectin) comprises the following amino acid sequence:, Derived homologs, mutants fragments and fused proteins, possessing immunological activity useful against P. aeruginosa; vaccines against P. aeruginosa infection which contain such materials; the gene encoding the PA-I recombinant polypeptide; related polypeptides and polynucleotides; a method for detecting a suspect P. aeruginosa strain; fused proteins having immunomodulatory, antibacterial, antiviral and antitumor activity; an immune cell or a tumor cell containing as an implant a PA-I encoding polynucleotide and a method for treating, cancer by administering to …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 27, 1993. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 27, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 27, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.